Medical Condition News

RSS
Scientists one step closer to developing new treatment for inflammatory bowel disease

Scientists one step closer to developing new treatment for inflammatory bowel disease

New single-agent phototherapy system may form valuable new tool to combat cancer

New single-agent phototherapy system may form valuable new tool to combat cancer

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Patients who take cholesterol medications before endovascular surgery experience better outcomes

Patients who take cholesterol medications before endovascular surgery experience better outcomes

University of Leicester hosts sports event to raise awareness of Nystagmus

University of Leicester hosts sports event to raise awareness of Nystagmus

UNM CCC biostatisticians help scientists conduct research on cancer

UNM CCC biostatisticians help scientists conduct research on cancer

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

Adelaide researchers identify key protein involved in 'super-inflammatory' immune response

Adelaide researchers identify key protein involved in 'super-inflammatory' immune response

Economically disadvantaged immigrants of non-English speaking Latinos exposed to harmful air pollution

Economically disadvantaged immigrants of non-English speaking Latinos exposed to harmful air pollution

New TSRI study highlights urgent need for new treatments to fight growing cancer metastases

New TSRI study highlights urgent need for new treatments to fight growing cancer metastases

Four Radboud researchers receive ERC grants to form research group

Four Radboud researchers receive ERC grants to form research group

New research shows that autophagy can operate in cell nucleus to guard against start of cancer

New research shows that autophagy can operate in cell nucleus to guard against start of cancer

Rutgers Cancer Institute scientist leads phase III trial of FDA-approved viral melanoma therapy

Rutgers Cancer Institute scientist leads phase III trial of FDA-approved viral melanoma therapy

Older women who complain of memory problems may experience thinking impairment decades later

Older women who complain of memory problems may experience thinking impairment decades later

Rush awarded $2.45 million grant to support quality care for older Americans

Rush awarded $2.45 million grant to support quality care for older Americans

UAB researcher awarded NIH grant to study pathogenesis of thrombotic microangiopathy

UAB researcher awarded NIH grant to study pathogenesis of thrombotic microangiopathy

Dementia specialists, PET imaging providers can now register to participate in IDEAS Study

Dementia specialists, PET imaging providers can now register to participate in IDEAS Study

GDF10 molecule identified as a key player in repair mechanisms after stroke

GDF10 molecule identified as a key player in repair mechanisms after stroke

New technique may enable in-flight detection of hypoxia in pilots

New technique may enable in-flight detection of hypoxia in pilots

Upstream Medical Technologies formed to revolutionise accurate diagnosis of heart conditions

Upstream Medical Technologies formed to revolutionise accurate diagnosis of heart conditions

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.